European Penny Stocks To Watch In July 2026

As geopolitical tensions and energy market volatility take center stage, European markets have experienced a downturn, with the STOXX Europe 600 Index closing down 1.79% recently. Despite these challenges, investors are still keen on exploring opportunities within smaller or newer companies that may offer unique growth potential. Penny stocks, though an outdated term, continue to attract attention due to their potential for significant returns when backed by strong financials. In this article, we explore three European penny stocks demonstrating financial strength and potential for long-term success amidst the current market conditions.

Let's dive into some prime choices out of the screener.

Biomark Diagnostics (DB:20B)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Biomark Diagnostics Inc. focuses on developing early-stage cancer diagnostic technology platforms for detection and treatment, with a market cap of €33.65 million.

Operations: The company generates CA$0.09 million in revenue from its advanced stage cancer diagnostic business segment.

Market Cap: €33.65M

BioMark Diagnostics Inc. is a pre-revenue company focusing on early-stage cancer diagnostics, with recent patent allowances from the Canadian and European offices for its lung cancer detection technology. These patents validate BioMark's innovative metabolomics platform across diverse populations, enhancing its potential for international partnerships and commercial launches. Despite having no significant revenue streams yet, the company is debt-free with short-term assets covering liabilities. However, it faces financial challenges with less than a year of cash runway and high share price volatility. The experienced management team remains focused on leveraging intellectual property to drive future growth opportunities in global markets.

• Unlock comprehensive insights into our analysis of Biomark Diagnostics stock in this financial health report.
• Explore historical data to track Biomark Diagnostics' performance over time in our past results report.

GreenMerc (NGM:GMERC B)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: GreenMerc AB (publ) is a fintech company based in Sweden that provides a software platform for digital assets and traditional fintech services, with a market cap of SEK55.46 million.

Operations: The company's revenue is derived entirely from its Data Processing segment, amounting to SEK23.82 million.

Market Cap: SEK55.46M

GreenMerc AB, a fintech company based in Sweden, has experienced declining financial performance with first-quarter revenue dropping to SEK4.21 million from SEK9.57 million the previous year. The company posted a net loss of SEK4.61 million compared to a net income of SEK2.81 million last year, highlighting its current unprofitability and negative return on equity (-32.94%). Despite having no debt and short-term assets exceeding liabilities, GreenMerc's high share price volatility remains concerning for investors seeking stability in penny stocks. The company's dividend yield is unsustainable due to insufficient earnings coverage, further complicating its financial outlook amidst ongoing challenges.

• Navigate through the intricacies of GreenMerc with our comprehensive balance sheet health report here.
• Gain insights into GreenMerc's past trends and performance with our report on the company's historical track record.

Flexion Mobile (OM:FLEXM)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Flexion Mobile Plc, with a market cap of SEK157.53 million, offers marketing services for gaming in the United Kingdom.

Operations: The company generates revenue primarily from its Distribution segment, which accounts for £65.98 million, and Marketing Services, contributing £6.54 million.

Market Cap: SEK157.53M

Flexion Mobile Plc has shown potential in the penny stock market with its focus on alternative app store distribution, generating £65.98 million from its Distribution segment and £6.54 million from Marketing Services. Despite being unprofitable with a negative return on equity of -184.14%, the company boasts a seasoned management team and board, averaging 12.3 and 8.1 years in tenure respectively, which could provide strategic direction for growth. Recent executive changes include appointing Ross Logan as director, bringing expertise in high-growth gaming businesses that may enhance Flexion's strategic initiatives despite its current financial challenges.

• Get an in-depth perspective on Flexion Mobile's performance by reading our balance sheet health report here.
• Assess Flexion Mobile's previous results with our detailed historical performance reports.

Taking Advantage

• Discover the full array of 309 European Penny Stocks right here.
• Interested In Other Possibilities? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com